University of Vienna
Researchers at the University of Vienna have developed fluorescent peptide tracers that can simultaneously visualise and activate the oxytocin receptor. This receptor–also known as the love/bonding hormone receptor–plays a key role in processes related to social behaviour, health and disease. These tracers create new possibilities for imaging and functional analysis in various biological systems–with far-reaching implications for fundamental research as well as for breast cancer diagnostics and therapy. The development of the tracers is described in the current issue of the renowned journal Angewandte Chemie, International Edition, and the tracers have recently been patented.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
